세계의 분산형 임상시험 시장 보고서(2025년)

Decentralized clinical trials are an innovative approach to conducting clinical research that utilizes digital tools and remote processes to engage participants outside traditional trial sites. They streamline data collection and monitoring in real time, improving trial efficiency. Decentralized clinical trials also enhance accessibility, allowing broader and more diverse participation, and accelerate research timelines while reducing operational challenges.

The primary types of decentralized clinical trials are interventional, observational, and expanded access. Interventional trials involve assigning participants to specific interventions to assess their effects on health outcomes. Key technologies include wearable devices, mobile health applications, telemedicine platforms, and electronic data capture systems. These trials span study phases from phase I through phase IV and are applied across therapeutic areas such as oncology, cardiology, neurology, and infectious diseases. End-users include pharmaceutical companies, biotechnology firms, contract research organizations, regulatory authorities, and academic and research institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The decentralized clinical trials market research report is one of a series of new reports from The Business Research Company that provides decentralized clinical trials market statistics, including decentralized clinical trials industry global market size, regional shares, competitors with a decentralized clinical trials market share, detailed decentralized clinical trials market segments, market trends and opportunities, and any further data you may need to thrive in the decentralized clinical trials industry. The decentralized clinical trials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The decentralized clinical trials market size has grown rapidly in recent years. It will grow from $7.44 billion in 2024 to $8.77 billion in 2025 at a compound annual growth rate (CAGR) of 17.8%. Growth in the historic period was driven by the rising adoption of electronic data capture systems, increasing use of wearable health monitoring devices, growing regulatory support for patient-centric trials, higher demand for cost-efficient trial models, and expansion of remote monitoring technologies.

The decentralized clinical trials market size is expected to see rapid growth in the next few years. It will grow to $16.68 billion in 2029 at a compound annual growth rate (CAGR) of 17.5%. Growth in the forecast period is expected to be supported by the integration of artificial intelligence and machine learning in clinical trials, greater adoption of blockchain for data security, rising prevalence of rare and chronic diseases promoting decentralized trial models, increased use of real-world evidence in trial design, and expansion of 5G connectivity enabling seamless trial operations. Key trends anticipated for the forecast period include the integration of AI and machine learning, adoption of wearable and biosensor technologies, increased use of telemedicine and remote monitoring, blockchain-enabled data security and transparency, and growth of cloud-based clinical trial management platforms.

The increasing emphasis on telemedicine is expected to support the growth of the decentralized clinical trials market in the years ahead. Telemedicine refers to the remote delivery of healthcare services through digital communication tools, allowing patients to receive consultations and monitoring without visiting healthcare facilities in person. This shift toward telemedicine is largely driven by the demand for accessible healthcare in response to global health challenges and social distancing measures. Decentralized clinical trials leverage telemedicine to remotely engage participants and monitor their progress, reducing the need for physical site visits while enabling real-time data collection, broader participation, and continuous oversight. For example, in August 2023, Vivalink, a healthcare technology company based in the United States, reported that eighty-one percent of clinicians were using remote patient monitoring, a significant increase from twenty percent in 2021. In addition, eighty-four percent of those currently using remote patient monitoring intended to expand their use in 2024. As a result, the growing focus on telemedicine is contributing to the expansion of the decentralized clinical trials market.

Companies operating in the decentralized clinical trials market are advancing their offerings by developing all-in-one, no-code clinical trial software solutions that simplify trial setup and improve efficiency and patient engagement. These platforms enable researchers to create and manage trials without writing code, while incorporating essential functions such as patient recruitment, data collection, monitoring, and analytics into one user-friendly system. For example, in August 2024, Medable, a clinical technology company based in the United States, introduced Medable Studio, an all-in-one, no-code software platform designed to streamline the configuration, translation, validation, and launch of electronic Clinical Outcome Assessments, electronic consent, remote consultations, and sensor integrations in clinical trials. This tool allows biopharmaceutical companies to develop protocol-specific study designs in a matter of hours rather than months, offering increased control, speed, and transparency. Users can choose from self-service, full-service, or hybrid options, which significantly shorten study startup timelines and reduce costs. The platform aims to transform trial execution by making the study setup process faster and less reliant on external services.

In July 2023, Signant Health, a United States-based provider of evidence generation solutions for modern clinical trials, completed the acquisition of DSG Incorporated for an undisclosed sum. This acquisition is intended to expand Signant Health's suite of electronic clinical solutions by incorporating DSG's unified electronic data capture and direct data capture platform. The integration of these technologies offers flexible and comprehensive support for both traditional and decentralized clinical trials. This move enhances operational efficiency, simplifies trial workflows, and improves digital tools available to sponsors, research sites, and clinical research organizations. DSG Incorporated is a United States-based company that provides electronic data capture and direct data capture technology within a unified clinical platform for use in site-based and decentralized clinical trials.

Major players in the decentralized clinical trials market are Walgreens Boots Alliance Inc., Pfizer Inc., Oracle Corporation, Thermo Fisher Scientific Inc., IQVIA Holdings Inc., Labcorp Holdings Inc., ICON Public Limited Company, Dassault Systemes SE, LEO Pharma A/S, Verily Life Sciences LLC, ProPharma, Signant Health Holding Corp., PCM Trials, Huma Therapeutics Limited, Medable Inc., Science 37 Inc., Obvio Health, EmVenio Research Inc., Grove AI Inc., Phesi Inc.

North America was the largest region in the decentralized clinical trials market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in decentralized clinical trials report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the decentralized clinical trials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The decentralized clinical trials market consists of revenues earned by entities by providing services such as patient recruitment and retention, site management and monitoring, data management and analytics, regulatory compliance support, and telemedicine or virtual care solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The decentralized clinical trials market also includes sales of wearable health monitoring devices, electronic data capture systems, biosensors, remote patient monitoring equipment, and clinical trial management software. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities, wholesalers, distributors, and retailers or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Decentralized Clinical Trials Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on decentralized clinical trials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for decentralized clinical trials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The decentralized clinical trials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Interventional; Observational; Expanded Access
• 2) By Technology Used: Wearable Devices; Mobile Health Applications; Telemedicine Platforms; Electronic Data Capture Systems
• 3) By Study Phase: Phase I; Phase II; Phase III; Phase IV
• 4) By Therapeutic Area: Oncology; Cardiology; Neurology; Infectious Diseases
• 5) By End-User: Pharmaceutical Companies; Biotechnology Firms; Contract Research Organizations; Regulatory Authorities; Academic And Research Institutions
• Subsegments:
• 1) By Interventional: Randomized Controlled Trials (RCTs); Non-Randomized Trials; Adaptive Clinical Trials; Pragmatic Clinical Trials
• 2) By Observational: Cohort Studies; Case-Control Studies; Cross-Sectional Studies; Prospective Studies; Retrospective Studies; Longitudinal Studies
• 3) By Expanded Access: Treatment Investigational New Drug (IND) Applications; Intermediate-Size Patient Population Investigational New Drug (IND) Applications; Single-Patient Investigational New Drug (IND) Applications; Emergency Use Investigational New Drug (IND) Applications
• Companies Mentioned: Walgreens Boots Alliance Inc.; Pfizer Inc.; Oracle Corporation; Thermo Fisher Scientific Inc.; IQVIA Holdings Inc.; Labcorp Holdings Inc.; ICON Public Limited Company; Dassault Systemes SE; LEO Pharma A/S; Verily Life Sciences LLC; ProPharma; Signant Health Holding Corp.; PCM Trials; Huma Therapeutics Limited; Medable Inc.; Science 37 Inc.; Obvio Health; EmVenio Research Inc.; Grove AI Inc.; Phesi Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Decentralized Clinical Trials Market Characteristics

3. Decentralized Clinical Trials Market Trends And Strategies

4. Decentralized Clinical Trials Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Decentralized Clinical Trials Growth Analysis And Strategic Analysis Framework

• 5.1. Global Decentralized Clinical Trials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Decentralized Clinical Trials Market Growth Rate Analysis
• 5.4. Global Decentralized Clinical Trials Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Decentralized Clinical Trials Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Decentralized Clinical Trials Total Addressable Market (TAM)

6. Decentralized Clinical Trials Market Segmentation

• 6.1. Global Decentralized Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Interventional
• Observational
• Expanded Access
• 6.2. Global Decentralized Clinical Trials Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Wearable Devices
• Mobile Health Applications
• Telemedicine Platforms
• Electronic Data Capture Systems
• 6.3. Global Decentralized Clinical Trials Market, Segmentation By Study Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Phase I
• Phase II
• Phase III
• Phase IV
• 6.4. Global Decentralized Clinical Trials Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Cardiology
• Neurology
• Infectious Diseases
• 6.5. Global Decentralized Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Companies
• Biotechnology Firms
• Contract Research Organizations
• Regulatory Authorities
• Academic And Research Institutions
• 6.6. Global Decentralized Clinical Trials Market, Sub-Segmentation Of Interventional, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Randomized Controlled Trials (RCTs)
• Non-Randomized Trials
• Adaptive Clinical Trials
• Pragmatic Clinical Trials
• 6.7. Global Decentralized Clinical Trials Market, Sub-Segmentation Of Observational, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cohort Studies
• Case-Control Studies
• Cross-Sectional Studies
• Prospective Studies
• Retrospective Studies
• Longitudinal Studies
• 6.8. Global Decentralized Clinical Trials Market, Sub-Segmentation Of Expanded Access, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Treatment Investigational New Drug (IND) Applications
• Intermediate-Size Patient Population Investigational New Drug (IND) Applications
• Single-Patient Investigational New Drug (IND) Applications
• Emergency Use Investigational New Drug (IND) Applications

7. Decentralized Clinical Trials Market Regional And Country Analysis

• 7.1. Global Decentralized Clinical Trials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Decentralized Clinical Trials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Decentralized Clinical Trials Market

• 8.1. Asia-Pacific Decentralized Clinical Trials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Decentralized Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Decentralized Clinical Trials Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Decentralized Clinical Trials Market, Segmentation By Study Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Decentralized Clinical Trials Market

• 9.1. China Decentralized Clinical Trials Market Overview
• 9.2. China Decentralized Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Decentralized Clinical Trials Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Decentralized Clinical Trials Market, Segmentation By Study Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Decentralized Clinical Trials Market

• 10.1. India Decentralized Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Decentralized Clinical Trials Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Decentralized Clinical Trials Market, Segmentation By Study Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Decentralized Clinical Trials Market

• 11.1. Japan Decentralized Clinical Trials Market Overview
• 11.2. Japan Decentralized Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Decentralized Clinical Trials Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Decentralized Clinical Trials Market, Segmentation By Study Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Decentralized Clinical Trials Market

• 12.1. Australia Decentralized Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Decentralized Clinical Trials Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Decentralized Clinical Trials Market, Segmentation By Study Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Decentralized Clinical Trials Market

• 13.1. Indonesia Decentralized Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Decentralized Clinical Trials Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Decentralized Clinical Trials Market, Segmentation By Study Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Decentralized Clinical Trials Market

• 14.1. South Korea Decentralized Clinical Trials Market Overview
• 14.2. South Korea Decentralized Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Decentralized Clinical Trials Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Decentralized Clinical Trials Market, Segmentation By Study Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Decentralized Clinical Trials Market

• 15.1. Western Europe Decentralized Clinical Trials Market Overview
• 15.2. Western Europe Decentralized Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Decentralized Clinical Trials Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Decentralized Clinical Trials Market, Segmentation By Study Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Decentralized Clinical Trials Market

• 16.1. UK Decentralized Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Decentralized Clinical Trials Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Decentralized Clinical Trials Market, Segmentation By Study Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Decentralized Clinical Trials Market

• 17.1. Germany Decentralized Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Decentralized Clinical Trials Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Decentralized Clinical Trials Market, Segmentation By Study Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Decentralized Clinical Trials Market

• 18.1. France Decentralized Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Decentralized Clinical Trials Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Decentralized Clinical Trials Market, Segmentation By Study Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Decentralized Clinical Trials Market

• 19.1. Italy Decentralized Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Decentralized Clinical Trials Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Decentralized Clinical Trials Market, Segmentation By Study Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Decentralized Clinical Trials Market

• 20.1. Spain Decentralized Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Decentralized Clinical Trials Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Decentralized Clinical Trials Market, Segmentation By Study Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Decentralized Clinical Trials Market

• 21.1. Eastern Europe Decentralized Clinical Trials Market Overview
• 21.2. Eastern Europe Decentralized Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Decentralized Clinical Trials Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Decentralized Clinical Trials Market, Segmentation By Study Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Decentralized Clinical Trials Market

• 22.1. Russia Decentralized Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Decentralized Clinical Trials Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Decentralized Clinical Trials Market, Segmentation By Study Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Decentralized Clinical Trials Market

• 23.1. North America Decentralized Clinical Trials Market Overview
• 23.2. North America Decentralized Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Decentralized Clinical Trials Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Decentralized Clinical Trials Market, Segmentation By Study Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Decentralized Clinical Trials Market

• 24.1. USA Decentralized Clinical Trials Market Overview
• 24.2. USA Decentralized Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Decentralized Clinical Trials Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Decentralized Clinical Trials Market, Segmentation By Study Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Decentralized Clinical Trials Market

• 25.1. Canada Decentralized Clinical Trials Market Overview
• 25.2. Canada Decentralized Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Decentralized Clinical Trials Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Decentralized Clinical Trials Market, Segmentation By Study Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Decentralized Clinical Trials Market

• 26.1. South America Decentralized Clinical Trials Market Overview
• 26.2. South America Decentralized Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Decentralized Clinical Trials Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Decentralized Clinical Trials Market, Segmentation By Study Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Decentralized Clinical Trials Market

• 27.1. Brazil Decentralized Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Decentralized Clinical Trials Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Decentralized Clinical Trials Market, Segmentation By Study Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Decentralized Clinical Trials Market

• 28.1. Middle East Decentralized Clinical Trials Market Overview
• 28.2. Middle East Decentralized Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Decentralized Clinical Trials Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Decentralized Clinical Trials Market, Segmentation By Study Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Decentralized Clinical Trials Market

• 29.1. Africa Decentralized Clinical Trials Market Overview
• 29.2. Africa Decentralized Clinical Trials Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Decentralized Clinical Trials Market, Segmentation By Technology Used, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Decentralized Clinical Trials Market, Segmentation By Study Phase, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Decentralized Clinical Trials Market Competitive Landscape And Company Profiles

• 30.1. Decentralized Clinical Trials Market Competitive Landscape
• 30.2. Decentralized Clinical Trials Market Company Profiles
  • 30.2.1. Walgreens Boots Alliance Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Oracle Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Decentralized Clinical Trials Market Other Major And Innovative Companies

• 31.1. Labcorp Holdings Inc.
• 31.2. ICON Public Limited Company
• 31.3. Dassault Systemes SE
• 31.4. LEO Pharma A/S
• 31.5. Verily Life Sciences LLC
• 31.6. ProPharma
• 31.7. Signant Health Holding Corp.
• 31.8. PCM Trials
• 31.9. Huma Therapeutics Limited
• 31.10. Medable Inc.
• 31.11. Science 37 Inc.
• 31.12. Obvio Health
• 31.13. EmVenio Research Inc.
• 31.14. Grove AI Inc.
• 31.15. Phesi Inc.

32. Global Decentralized Clinical Trials Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Decentralized Clinical Trials Market

34. Recent Developments In The Decentralized Clinical Trials Market

35. Decentralized Clinical Trials Market High Potential Countries, Segments and Strategies

• 35.1 Decentralized Clinical Trials Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Decentralized Clinical Trials Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Decentralized Clinical Trials Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer